Literature DB >> 17323178

Negative effects of nicotine on bone-resorbing cytokines and bone histomorphometric parameters in male rats.

Hermizi Hapidin1, Faizah Othman, Ima-Nirwana Soelaiman, Ahmad N Shuid, Douglas A Luke, Norazlina Mohamed.   

Abstract

The effects of nicotine administration on bone-resorbing cytokines, cotinine, and bone histomorphometric parameters were studied in 21 Sprague-Dawley male rats. Rats aged 3 months and weighing 250-300 g were divided into three groups. Group 1 was the baseline control (BC), which was killed without treatment. The other two groups were the control group (C) and the nicotine-treated group (N). The N group was treated with nicotine 7 mg/kg body weight and the C group was treated with normal saline only. Treatment was given by intraperitoneal injection for 6 days/week for 4 months. The rats were injected intraperitoneally with calcein 20 mg/kg body weight at day 9 and day 2 before they were killed. ELISA test kits were used to measure the serum interleukin-1 (IL-1), interleukin-6 (IL-6), and cotinine (a metabolite of nicotine) levels at the beginning of the study and upon completion of the study. Histomorphometric analysis was done on the metaphyseal region of the trabecular bone of the left femur by using an image analyzer. Biochemical analysis revealed that nicotine treatment for 4 months significantly increased the serum IL-1, IL-6, and cotinine levels as compared to pretreatment levels. In addition, the serum cotinine level was significantly higher in the N group than in the C group after 4 months treatment. Histomorphometric analysis showed that nicotine significantly decreased the trabecular bone volume (BV/TV), trabecular thickness (Tb.Th), double-labeled surface (dLS/BS), mineralizing surface (MS/BS), mineral appositional rate (MAR), and bone formation rate (BFR/BS), while causing an increase in the single-labeled surface (sLS/BS), osteoclast surface (Oc.S/BS), and eroded surface (ES/BS) as compared to the BC and C groups. In conclusion, treatment with nicotine 7 mg/kg for 4 months was detrimental to bone by causing an increase in the bone resorbing cytokines and cotinine levels. Nicotine also exerted negative effects on the dynamic trabecular histomorphometric parameters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323178     DOI: 10.1007/s00774-006-0733-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  34 in total

Review 1.  Cotinine as a biomarker of environmental tobacco smoke exposure.

Authors:  N L Benowitz
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

2.  Stereologic techniques in microscopy.

Authors:  R H Hfreere; E R Weibel
Journal:  J R Microsc Soc       Date:  1967

3.  Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay.

Authors:  Ulrich E Ziegler; Jens Kauczok; Ulrich Andreas Dietz; H Bernd Reith; Karsten Schmidt
Journal:  Pharmacology       Date:  2004-12       Impact factor: 2.547

4.  Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.

Authors:  A Grey; M A Mitnick; S Shapses; A Ellison; C Gundberg; K Insogna
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

5.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.

Authors:  N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1993-03       Impact factor: 6.875

6.  Cotinine disposition and effects.

Authors:  N L Benowitz; F Kuyt; P Jacob; R T Jones; A L Osman
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

7.  Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.

Authors:  L Nguyen; F E Dewhirst; P V Hauschka; P Stashenko
Journal:  Lymphokine Cytokine Res       Date:  1991-04

8.  Free radical production in nicotine treated pancreatic tissue.

Authors:  G J Wetscher; M Bagchi; D Bagchi; G Perdikis; P R Hinder; K Glaser; R A Hinder
Journal:  Free Radic Biol Med       Date:  1995-05       Impact factor: 7.376

9.  Practical stereological methods for morphometric cytology.

Authors:  E R Weibel; G S Kistler; W F Scherle
Journal:  J Cell Biol       Date:  1966-07       Impact factor: 10.539

10.  Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar.

Authors:  W A Pryor; D G Prier; D F Church
Journal:  Environ Health Perspect       Date:  1983-01       Impact factor: 9.031

View more
  22 in total

1.  Antimicrobial photodynamic therapy minimizes the deleterious effect of nicotine in female rats with induced periodontitis.

Authors:  Erivan Clementino Gualberto; Letícia Helena Theodoro; Mariellén Longo; Vivian Cristina Noronha Novaes; Maria José Hitomi Nagata; Edilson Ervolino; Valdir Gouveia Garcia
Journal:  Lasers Med Sci       Date:  2015-11-06       Impact factor: 3.161

Review 2.  The effects of smoking on bone metabolism.

Authors:  V Yoon; N M Maalouf; K Sakhaee
Journal:  Osteoporos Int       Date:  2012-02-21       Impact factor: 4.507

3.  The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.

Authors:  M A Hurchla; A Garcia-Gomez; M C Hornick; E M Ocio; A Li; J F Blanco; L Collins; C J Kirk; D Piwnica-Worms; R Vij; M H Tomasson; A Pandiella; J F San Miguel; M Garayoa; K N Weilbaecher
Journal:  Leukemia       Date:  2012-07-05       Impact factor: 11.528

4.  The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.

Authors:  Angela C Hirbe; Anke J Roelofs; Desiree H Floyd; Hongju Deng; Stephanie N Becker; Lisa G Lanigan; Anthony J Apicelli; Zhiqiang Xu; Julie L Prior; Mark C Eagleton; David Piwnica-Worms; Michael J Rogers; Katherine Weilbaecher
Journal:  Bone       Date:  2009-01-23       Impact factor: 4.398

5.  Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats.

Authors:  Ruchun Dai; Yulin Ma; Zhifeng Sheng; Yan Jin; Yuhai Zhang; Lingna Fang; Huijie Fan; Eryuan Liao
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

6.  Effect of epimedium pubescen flavonoid on bone mineral status and bone turnover in male rats chronically exposed to cigarette smoke.

Authors:  Shu-guang Gao; Ling Cheng; Kang-hua Li; Wen-He Liu; Mai Xu; Wei Jiang; Li-Cheng Wei; Fang-jie Zhang; Wen-feng Xiao; Yi-lin Xiong; Jian Tian; Chao Zeng; Jin-peng Sun; Qiang Xie; Guang-hua Lei
Journal:  BMC Musculoskelet Disord       Date:  2012-06-19       Impact factor: 2.362

7.  The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.

Authors:  Daniel A Rauch; Michelle A Hurchla; John C Harding; Hongju Deng; Lauren K Shea; Mark C Eagleton; Stefan Niewiesk; Michael D Lairmore; David Piwnica-Worms; Thomas J Rosol; Jason D Weber; Lee Ratner; Katherine N Weilbaecher
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

8.  Bone turnover in passive smoking female rat: relationships to change in bone mineral density.

Authors:  Shu-guang Gao; Kang-hua Li; Mai Xu; Wei Jiang; Hong Shen; Wei Luo; Wen-shuo Xu; Jian Tian; Guang-hua Lei
Journal:  BMC Musculoskelet Disord       Date:  2011-06-11       Impact factor: 2.362

9.  Effect of nicotine on orthodontic tooth movement and bone remodeling in rats.

Authors:  Sung-Hee Lee; Jung-Yul Cha; Sung-Hwan Choi; Baek-Il Kim; Jae-Kook Cha; Chung-Ju Hwang
Journal:  Korean J Orthod       Date:  2021-07-25       Impact factor: 1.372

10.  Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.

Authors:  Hideki Tanaka; Natsuko Tanabe; Takayuki Kawato; Kumiko Nakai; Taro Kariya; Sakurako Matsumoto; Ning Zhao; Masafumi Motohashi; Masao Maeno
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.